Clinical trials for Gastro-oesophageal reflux disease

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Gastro-oesophageal reflux disease. For all clinical trials, go to clinical trials search

This list shows clinical trials for Gastro-oesophageal reflux disease

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Gastro-oesophageal reflux disease
Title Recruitment status Location
A randomised, double blind placebo controlled study in patients with reflux symptoms to assess suppression of gastro-oesophageal reflux by ‘Gaviscon Double Action Peppermint liquid’ using the BRAVO system - Gaviscon Double Action vs placebo study Not Recruiting United Kingdom
Consultants and Physiology technicians: A comparative analysis of treatment pathways for patients with gastro oesophageal reflux disease and dysphagia. Not Recruiting United Kingdom
Efficacy of domperidone and/or omeprazole in the treatment of gastroesophageal reflux (GOR) in children - a comparative study Not Recruiting United Kingdom
Proton pump inhibitor (PPI) treatment of gastro-oesophageal reflux (GOR) associated with non-cardiac chest pain (NCCP) Not Recruiting United Kingdom
What constitutes a 'positive symptom index' for the diagnosis of gastro-oesophageal reflux- related pain? Not Recruiting United Kingdom
The place of minimal access surgery amongst people with gastro-oesophageal reflux disease (GORD) - a UK collaborative study Not Recruiting United Kingdom
A double-blind, double-dummy, randomised, study to assess the superiority of Zegerid® 20 mg vs. Losec® 20 mg in the rapid relief of heartburn associated with GERD as on demand therapy. Not Recruiting United Kingdom
Effect of Sildenafil on Pulmonary Artery Pressure during hypoxia and exercise in Chronic Heart Failure - Effect of sildenafil on PA pressure during exercise and hypoxia in CHF Not Recruiting United Kingdom
Not Recruiting United Kingdom
A double-blind, double-dummy, randomised, study to assess the superiority of Zegerid® 20 mg vs. Losec® 20 mg in the rapid relief of heartburn associated with GERD as on demand therapy. - Zegerid® vs. Losec® in the rapid relief of heartburn associated with GERD Not Recruiting United Kingdom

Page last reviewed: 02/03/2016

Next review due: 01/03/2019